Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             170 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses Honda-Okubo, Yoshikazu
2012
30 Supplement 5 p. 5373-5381
9 p.
artikel
2 Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine Breiman, Robert F.
2012
30 Supplement 5 p. A24-A29
nvt p.
artikel
3 An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge Hutnick, Natalie A.
2012
30 Supplement 5 p. 3202-3208
7 p.
artikel
4 Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA) Shibl, Atef M.
2012
30 Supplement 5 p. G32-G36
nvt p.
artikel
5 An update after 16 years of hepatitis B vaccination in South Africa Burnett, Rosemary J.
2012
30 Supplement 5 p. C45-C51
nvt p.
artikel
6 A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age Baxter, Roger
2012
30 Supplement 5 p. 3053-3060
8 p.
artikel
7 A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age Baxter, Roger
2012
30 Supplement 5 p. 2989-2998
10 p.
artikel
8 A retrospective epidemiological study of invasive pneumococcal infections in children aged 0–5 years in Bahrain from 1 January 1999 to 31 December 2003 Al Musawi, Muna
2012
30 Supplement 5 p. G2-G6
nvt p.
artikel
9 A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines Schiller, John T.
2012
30 Supplement 5 p. F123-F138
nvt p.
artikel
10 A review of the effect of immunization programs on antimicrobial utilization Wilby, Kyle J.
2012
30 Supplement 5 p. 6509-6514
6 p.
artikel
11 Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs Sanford, Brenton J.
2012
30 Supplement 5 p. 6249-6255
7 p.
artikel
12 Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life Wang, Yangyang
2012
30 Supplement 5 p. 5708-5713
6 p.
artikel
13 A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge Reynolds, Matthew R.
2012
30 Supplement 5 p. 4465-4475
11 p.
artikel
14 A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season Tennis, Patricia
2012
30 Supplement 5 p. 6099-6102
4 p.
artikel
15 A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China Lu, Li
2012
30 Supplement 5 p. 5094-5098
5 p.
artikel
16 Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1) Nayak, Baibaswata
2012
30 Supplement 5 p. 2220-2227
8 p.
artikel
17 A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose Richert, Laura E.
2012
30 Supplement 5 p. 3653-3665
13 p.
artikel
18 Barriers to HPV immunization for African American adolescent females Hamlish, Tamara
2012
30 Supplement 5 p. 6472-6476
5 p.
artikel
19 Birth order and private voluntary immunization—A study of 110,902 children Gavrielov-Yusim, Natalie
2012
30 Supplement 5 p. 442-447
6 p.
artikel
20 Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine Moffitt, Kristin L.
2012
30 Supplement 5 p. 4316-4322
7 p.
artikel
21 Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: A systematic review Kawai, Kosuke
2012
30 Supplement 5 p. 1244-1254
11 p.
artikel
22 Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy Ansaldi, Filippo
2012
30 Supplement 5 p. 2288-2294
7 p.
artikel
23 Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy Zanetti, Alessandro
2012
30 Supplement 5 p. 5770-5775
6 p.
artikel
24 Changes in seroprevalence to hepatitis A in Victoria, Australia: A comparison of three time points Heywood, A.E.
2012
30 Supplement 5 p. 6020-6026
7 p.
artikel
25 Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine Elberse, Karin E.M.
2012
30 Supplement 5 p. 7644-7651
8 p.
artikel
26 Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco) Elmdaghri, Naima
2012
30 Supplement 5 p. G46-G50
nvt p.
artikel
27 Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus Willems, Tom
2012
30 Supplement 5 p. 5849-5855
7 p.
artikel
28 Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study Opel, Douglas J.
2012
30 Supplement 5 p. 1269-1275
7 p.
artikel
29 Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination Menon, Vinay J.
2012
30 Supplement 5 p. 3136-3144
9 p.
artikel
30 Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori Mori, Jerneja
2012
30 Supplement 5 p. 5856-5863
8 p.
artikel
31 Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study Chatterjee, Archana
2012
30 Supplement 5 p. 3360-3368
9 p.
artikel
32 Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice Fu, Shulin
2012
30 Supplement 5 p. 6839-6844
6 p.
artikel
33 Contribution of Immunization Weeks toward improving coverage, access to services, and completion of recommended childhood vaccinations in Assam, India Ryman, Tove K.
2012
30 Supplement 5 p. 2551-2555
5 p.
artikel
34 Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation Cohen, Jonathan M.
2012
30 Supplement 5 p. 4453-4459
7 p.
artikel
35 Corrigendum to “Sendai virus-based RSV vaccine protects African green monkeys from RSV infection” [Vaccine 30 (5) (2012) 959–968] Jones, Bart G.
2012
30 Supplement 5 p. 6955-
1 p.
artikel
36 Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries – Quinvaxem®: The first 5 years Schmid, D.A.
2012
30 Supplement 5 p. 6241-6248
8 p.
artikel
37 Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour? Mather, Tanya
2012
30 Supplement 5 p. 3196-3201
6 p.
artikel
38 Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues Montiel, Nestor
2012
30 Supplement 5 p. 1690-1701
12 p.
artikel
39 Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults Moore, Sophie E.
2012
30 Supplement 5 p. 4842-4848
7 p.
artikel
40 Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand Muangchana, Charung
2012
30 Supplement 5 p. 2839-2847
9 p.
artikel
41 Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: A dynamic individual-based approach Vanni, Tazio
2012
30 Supplement 5 p. 4866-4871
6 p.
artikel
42 Editorial Board 2012
30 Supplement 5 p. CO2-
1 p.
artikel
43 Editorial Board 2012
30 Supplement 5 p. CO2-
1 p.
artikel
44 Editorial Board 2012
30 Supplement 5 p. CO2-
1 p.
artikel
45 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
46 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
47 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
48 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
49 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
50 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
51 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
52 Editorial Board/Aims and Scope 2012
30 Supplement 5 p. CO2-
1 p.
artikel
53 Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience Djingarey, Mamoudou H.
2012
30 Supplement 5 p. B40-B45
nvt p.
artikel
54 Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients Forstner, C.
2012
30 Supplement 5 p. 5449-5452
4 p.
artikel
55 Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan Khan, M. Imran
2012
30 Supplement 5 p. 5389-5395
7 p.
artikel
56 Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.) Abd Alla, Mohamed D.
2012
30 Supplement 5 p. 3068-3075
8 p.
artikel
57 Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies Rangelova, Desislava
2012
30 Supplement 5 p. 6376-6381
6 p.
artikel
58 Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles Garlapati, S.
2012
30 Supplement 5 p. 5206-5214
9 p.
artikel
59 Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon Hanna-Wakim, Rima
2012
30 Supplement 5 p. G11-G17
nvt p.
artikel
60 Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman Awaidy, Salah Thabit Al
2012
30 Supplement 5 p. G7-G10
nvt p.
artikel
61 Epstein–Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection Friis, Anna M.C.
2012
30 Supplement 5 p. 6093-6098
6 p.
artikel
62 Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice? Bilcke, Joke
2012
30 Supplement 5 p. 2795-2800
6 p.
artikel
63 Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana Abbott, Collette
2012
30 Supplement 5 p. 2582-2587
6 p.
artikel
64 Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer Arbyn, Marc
2012
30 Supplement 5 p. F88-F99
nvt p.
artikel
65 Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac Caron, François
2012
30 Supplement 5 p. 5059-5062
4 p.
artikel
66 Factors associated with HPV vaccine uptake in teenage girls: A systematic review Kessels, Sharon J.M.
2012
30 Supplement 5 p. 3546-3556
11 p.
artikel
67 Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south Frew, Paula M.
2012
30 Supplement 5 p. 4200-4208
9 p.
artikel
68 Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections Liu, Ge
2012
30 Supplement 5 p. 6833-6838
6 p.
artikel
69 Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5 Tanabe, Kazuyuki
2012
30 Supplement 5 p. 1583-1593
11 p.
artikel
70 Global Burden of Human Papillomavirus and Related Diseases Forman, David
2012
30 Supplement 5 p. F12-F23
nvt p.
artikel
71 Haemophilus influenzae type b conjugate vaccines – A South African perspective Visser, Adele
2012
30 Supplement 5 p. C52-C57
nvt p.
artikel
72 Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries Tu, Hong-Anh T.
2012
30 Supplement 5 p. 1521-1528
8 p.
artikel
73 Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003–2010: A retrospective ecological study Beck, Charles R.
2012
30 Supplement 5 p. 1965-1971
7 p.
artikel
74 High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs Wen, Ke
2012
30 Supplement 5 p. 1198-1207
10 p.
artikel
75 Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization Dekker, C.N.T.
2012
30 Supplement 5 p. 1379-1387
9 p.
artikel
76 Human Papillomavirus and Cancer Prevention: Gaps in Knowledge and Prospects for Research, Policy, and Advocacy Franco, Eduardo L.
2012
30 Supplement 5 p. F175-F182
nvt p.
artikel
77 Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis Gillison, Maura L.
2012
30 Supplement 5 p. F34-F54
nvt p.
artikel
78 Human Papillomavirus, Human Immunodeficiency Virus and Immunosuppression Denny, Lynette A.
2012
30 Supplement 5 p. F168-F174
nvt p.
artikel
79 Human Papillomavirus Vaccine Introduction – The First Five Years Markowitz, Lauri E.
2012
30 Supplement 5 p. F139-F148
nvt p.
artikel
80 Human Papillomavirus Vaccines – Immune Responses Stanley, Margaret
2012
30 Supplement 5 p. F83-F87
nvt p.
artikel
81 Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine Tomovici, A.
2012
30 Supplement 5 p. 2647-2653
7 p.
artikel
82 Immunogenicity of a lentiviral-based DNA vaccine driven by the 5′LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques Arrode-Brusés, Géraldine
2012
30 Supplement 5 p. 2956-2962
7 p.
artikel
83 Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age Van Der Meeren, Olivier
2012
30 Supplement 5 p. 2710-2714
5 p.
artikel
84 Immunogenicity of the pentavalent rotavirus vaccine in African infants Armah, George E.
2012
30 Supplement 5 p. A86-A93
nvt p.
artikel
85 Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales Andrews, Nick J.
2012
30 Supplement 5 p. 6802-6808
7 p.
artikel
86 Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait Mokaddas, Eiman
2012
30 Supplement 5 p. G37-G40
nvt p.
artikel
87 Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme Ingels, Helene
2012
30 Supplement 5 p. 3944-3950
7 p.
artikel
88 Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil Cardoso, Cristiane W.
2012
30 Supplement 5 p. 5541-5546
6 p.
artikel
89 Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening Coupé, Veerle M.H.
2012
30 Supplement 5 p. 1813-1822
10 p.
artikel
90 Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy Bechini, Angela
2012
30 Supplement 5 p. 6396-6401
6 p.
artikel
91 Implementation of Human Papillomavirus Immunization in the Developing World Kane, Mark A.
2012
30 Supplement 5 p. F192-F200
nvt p.
artikel
92 Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge Morello, Christopher S.
2012
30 Supplement 5 p. 6541-6550
10 p.
artikel
93 Individual-, family- and community-level determinants of full vaccination coverage among children aged 12–23 months in western Kenya Kawakatsu, Yoshito
2012
30 Supplement 5 p. 7588-7593
6 p.
artikel
94 Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands Shafique, Muhammad
2012
30 Supplement 5 p. 597-606
10 p.
artikel
95 Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo Daenthanasanmak, Anusara
2012
30 Supplement 5 p. 5118-5131
14 p.
artikel
96 International collaborative proficiency study of Human Papillomavirus type 16 serology Eklund, Carina
2012
30 Supplement 5 p. 294-299
6 p.
artikel
97 Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection Hong, Seol Hee
2012
30 Supplement 5 p. 466-474
9 p.
artikel
98 Introducing human papillomavirus vaccines into the health system in South Africa Botha, Matthys H.
2012
30 Supplement 5 p. C28-C34
nvt p.
artikel
99 Introduction 2012
30 Supplement 5 p. xii-
1 p.
artikel
100 Introduction of Human Papillomavirus DNA Screening in the World: 15 Years of Experience Castle, Philip E.
2012
30 Supplement 5 p. F117-F122
nvt p.
artikel
101 Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa Schoub, Barry D.
2012
30 Supplement 5 p. C35-C37
nvt p.
artikel
102 Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: Translating research into policy Madhi, Shabir A.
2012
30 Supplement 5 p. C21-C27
nvt p.
artikel
103 Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003–2009 von Gottberg, Anne
2012
30 Supplement 5 p. 565-571
7 p.
artikel
104 In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system Childs, Tawanna S.
2012
30 Supplement 5 p. 5942-5948
7 p.
artikel
105 Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine Song, Manki
2012
30 Supplement 5 p. 3266-3277
12 p.
artikel
106 Lack of association between childhood immunizations and encephalitis in California, 1998–2008 Pahud, Barbara A.
2012
30 Supplement 5 p. 247-253
7 p.
artikel
107 Lessons from an online debate about measles–mumps–rubella (MMR) immunization Nicholson, Michelle S.
2012
30 Supplement 5 p. 3806-3812
7 p.
artikel
108 Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus Heath, David D.
2012
30 Supplement 5 p. 7321-7326
6 p.
artikel
109 Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program? Morin, Alyssa
2012
30 Supplement 5 p. 5921-5927
7 p.
artikel
110 Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries Canfell, Karen
2012
30 Supplement 5 p. F157-F167
nvt p.
artikel
111 Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine Desai, Kamal
2012
30 Supplement 5 p. 2510-2515
6 p.
artikel
112 Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi Nakagomi, Toyoko
2012
30 Supplement 5 p. A140-A151
nvt p.
artikel
113 Monitoring of rotavirus vaccination in Morocco: Establishing the baseline burden of rotavirus disease Benhafid, Mohammed
2012
30 Supplement 5 p. 6515-6520
6 p.
artikel
114 Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes Kennedy, Richard B.
2012
30 Supplement 5 p. 2159-2167
9 p.
artikel
115 New Technologies and Procedures for Cervical Cancer Screening Cuzick, Jack
2012
30 Supplement 5 p. F107-F116
nvt p.
artikel
116 New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs Chauke-Moagi, Bafedile E.
2012
30 Supplement 5 p. C3-C8
nvt p.
artikel
117 Non-specific and sex-differential effects of vaccinations on child survival in rural western India Hirve, Siddhivinayak
2012
30 Supplement 5 p. 7300-7308
9 p.
artikel
118 Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study Charfi, F.
2012
30 Supplement 5 p. G18-G24
nvt p.
artikel
119 Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses Poljak, Mario
2012
30 Supplement 5 p. F100-F106
nvt p.
artikel
120 Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice Ma, Wen-Jiang
2012
30 Supplement 5 p. 1437-1444
8 p.
artikel
121 Parental and societal values for the risks and benefits of childhood combination vaccines Gidengil, Courtney
2012
30 Supplement 5 p. 3445-3452
8 p.
artikel
122 Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations Khatami, Ameneh
2012
30 Supplement 5 p. 2831-2838
8 p.
artikel
123 Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance Nilsson, Lennart
2012
30 Supplement 5 p. 3239-3247
9 p.
artikel
124 Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide Zollinger, Wendell D.
2012
30 Supplement 5 p. 712-721
10 p.
artikel
125 Pneumococcal disease in South Australia: Vaccine success but no time for complacency Johnson, David R.
2012
30 Supplement 5 p. 2206-2211
6 p.
artikel
126 Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults Grabenstein, John D.
2012
30 Supplement 5 p. 4435-4444
10 p.
artikel
127 Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007–2009 Gessner, Bradford D.
2012
30 Supplement 5 p. G41-G45
nvt p.
artikel
128 Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children Azzari, Chiara
2012
30 Supplement 5 p. 2701-2705
5 p.
artikel
129 Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: A national survey Gargano, Lisa M.
2012
30 Supplement 5 p. 3541-3545
5 p.
artikel
130 Preface 2012
30 Supplement 5 p. viii-ix
nvt p.
artikel
131 Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates Bolton, Diane L.
2012
30 Supplement 5 p. 5991-5998
8 p.
artikel
132 Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030 Atherly, Deborah E.
2012
30 Supplement 5 p. A7-A14
nvt p.
artikel
133 Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China Liu, Na
2012
30 Supplement 5 p. 6940-6945
6 p.
artikel
134 Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway Lu, Chunxue
2012
30 Supplement 5 p. 475-485
11 p.
artikel
135 Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years Weycker, Derek
2012
30 Supplement 5 p. 5437-5444
8 p.
artikel
136 Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel Ben-Shimol, S.
2012
30 Supplement 5 p. 6600-6607
8 p.
artikel
137 Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine Swayne, David E.
2012
30 Supplement 5 p. 4964-4970
7 p.
artikel
138 Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases Bosch, F. Xavier
2012
30 Supplement 5 p. F1-F11
nvt p.
artikel
139 Reprint of: Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010 Tali-Maamar, H.
2012
30 Supplement 5 p. G25-G31
nvt p.
artikel
140 Research priorities for global measles and rubella control and eradication Goodson, James L.
2012
30 Supplement 5 p. 4709-4716
8 p.
artikel
141 Risk factors of underutilization of childhood immunizations in ultraorthodox Jewish communities in Israel despite high access to health care services Muhsen, Khitam
2012
30 Supplement 5 p. 2109-2115
7 p.
artikel
142 Rubella control in Papua New Guinea: Age-specific immunity informs strategies for introduction of rubella vaccine Riddell, Michaela
2012
30 Supplement 5 p. 7506-7512
7 p.
artikel
143 Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children Okada, Kenji
2012
30 Supplement 5 p. 5967-5972
6 p.
artikel
144 Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates Minervini, Gianmaria
2012
30 Supplement 5 p. 1476-1480
5 p.
artikel
145 Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens Stanberry, L.R.
2012
30 Supplement 5 p. 307-316
10 p.
artikel
146 School-located influenza immunization programs: Factors important to parents and students Middleman, Amy B.
2012
30 Supplement 5 p. 4993-4999
7 p.
artikel
147 Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa Tapia, Milagritos D.
2012
30 Supplement 5 p. A79-A85
nvt p.
artikel
148 Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria Giwa, F.J.
2012
30 Supplement 5 p. 6759-6765
7 p.
artikel
149 Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population Guevara, Silvia
2012
30 Supplement 5 p. 3857-3861
5 p.
artikel
150 The Biology and Life-Cycle of Human Papillomaviruses Doorbar, John
2012
30 Supplement 5 p. F55-F70
nvt p.
artikel
151 The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel Thompson, Mark G.
2012
30 Supplement 5 p. 3557-3565
9 p.
artikel
152 The feasibility of identifying children with primary immunodeficiency disorders: Preparation for the polio post-eradication era in Bangladesh Sazzad, Hossain M.S.
2012
30 Supplement 5 p. 5396-5400
5 p.
artikel
153 The immune modulation of Bacillus cereus var. Toyoi in mice immunized with experimental inactivated Bovine Herpesvirus Type 5 vaccine Roos, Talita Bandeira
2012
30 Supplement 5 p. 2173-2177
5 p.
artikel
154 The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda Anderson, Elizabeth J.
2012
30 Supplement 5 p. 2083-2089
7 p.
artikel
155 The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity – A preliminary study Hewson, Kylie A.
2012
30 Supplement 5 p. 4190-4199
10 p.
artikel
156 Therapy of Human Papillomavirus-Related Disease Stern, Peter L.
2012
30 Supplement 5 p. F71-F82
nvt p.
artikel
157 The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles Lobanova, Liubov M.
2012
30 Supplement 5 p. 3061-3067
7 p.
artikel
158 The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis Huang, Wan-Ting
2012
30 Supplement 5 p. 2168-2172
5 p.
artikel
159 The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence Usonis, Vytautas
2012
30 Supplement 5 p. 4596-4605
10 p.
artikel
160 Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers Velkers, Francisca C.
2012
30 Supplement 5 p. 322-328
7 p.
artikel
161 Understanding Human Papillomavirus Vaccine Uptake Fisher, William A.
2012
30 Supplement 5 p. F149-F156
nvt p.
artikel
162 Updating the Natural History of Human Papillomavirus and Anogenital Cancers Moscicki, Anna-Barbara
2012
30 Supplement 5 p. F24-F33
nvt p.
artikel
163 Upgrading Public Health Programs for Human Papillomavirus Prevention and Control is Possible in Low- and Middle-income Countries Steben, Marc
2012
30 Supplement 5 p. F183-F191
nvt p.
artikel
164 Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period De Serres, Gaston
2012
30 Supplement 5 p. 4067-4072
6 p.
artikel
165 Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis) Heath, David D.
2012
30 Supplement 5 p. 3076-3081
6 p.
artikel
166 Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight Wilson, Stephen
2012
30 Supplement 5 p. 7625-7629
5 p.
artikel
167 Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine Wendy, Bissinger
2012
30 Supplement 5 p. 5293-5297
5 p.
artikel
168 Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco Braikat, Mohamed
2012
30 Supplement 5 p. 2594-2599
6 p.
artikel
169 Vaccine shortages and suspect online pharmacy sellers Liang, Bryan A.
2012
30 Supplement 5 p. 105-108
4 p.
artikel
170 Workshop on intussusception in African countries – Meeting report Steele, A. Duncan
2012
30 Supplement 5 p. A185-A189
nvt p.
artikel
                             170 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland